706 related articles for article (PubMed ID: 30820607)
1. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
[TBL] [Abstract][Full Text] [Related]
2. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
[TBL] [Abstract][Full Text] [Related]
3. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
4. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling.
Yingjie K; Haihong Y; Lingwei C; Sen Z; Yuanting D; Shasha C; Liutong P; Ying W; Min Z
Biomed Pharmacother; 2019 Apr; 112():108681. PubMed ID: 30970510
[TBL] [Abstract][Full Text] [Related]
6. CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.
Liang H; Liao M; Zhao W; Zheng X; Xu F; Wang H; Huang J
Biomed Pharmacother; 2018 Feb; 98():347-356. PubMed ID: 29275176
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EZH2 ameliorates hyperoxaluria-induced kidney injury through the JNK/FoxO3a pathway.
Gao X; Peng Y; Fang Z; Li L; Ming S; Dong H; Li R; Zhu Y; Zhang W; Zhu B; Liao J; Wang Z; Liu M; Li W; Zeng J; Gao X
Life Sci; 2022 Feb; 291():120258. PubMed ID: 34952043
[TBL] [Abstract][Full Text] [Related]
8. Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury.
Zou S; Chen J; Zhou P; Xue M; Wu M; Wang L
Kidney Blood Press Res; 2024; 49(1):196-207. PubMed ID: 38368866
[TBL] [Abstract][Full Text] [Related]
9. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
[No Abstract] [Full Text] [Related]
10. Periostin induces kidney fibrosis after acute kidney injury via the p38 MAPK pathway.
An JN; Yang SH; Kim YC; Hwang JH; Park JY; Kim DK; Kim JH; Kim DW; Hur DG; Oh YK; Lim CS; Kim YS; Lee JP
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F426-F437. PubMed ID: 30539653
[TBL] [Abstract][Full Text] [Related]
11. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect.
Huang R; Zhou Q; Veeraragoo P; Yu H; Xiao Z
Ren Fail; 2011; 33(2):207-16. PubMed ID: 21332343
[TBL] [Abstract][Full Text] [Related]
12. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
14. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
15. Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.
Li Z; Deng X; Kang Z; Wang Y; Xia T; Ding N; Yin Y
J Nephrol; 2016 Feb; 29(1):27-36. PubMed ID: 26149640
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between Connexin32 and Mitochondrial Apoptotic Signaling Pathway Plays a Pivotal Role in Renal Ischemia Reperfusion-Induced Acute Kidney Injury.
Chen C; Yao W; Wu S; Zhou S; Ge M; Gu Y; Li X; Chen G; Bellanti JA; Zheng SG; Yuan D; Hei Z
Antioxid Redox Signal; 2019 Apr; 30(12):1521-1538. PubMed ID: 29790387
[No Abstract] [Full Text] [Related]
17. 6-Shogaol protects against ischemic acute kidney injury by modulating NF-κB and heme oxygenase-1 pathways.
Han SJ; Kim M; D'Agati VD; Lee HT
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F743-F756. PubMed ID: 31313953
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cell-Derived Conditioned Medium Attenuates Acute Kidney Injury by Downregulating the Oxidative Stress-Related Pathway in Ischemia-Reperfusion Rats.
Tarng DC; Tseng WC; Lee PY; Chiou SH; Hsieh SL
Cell Transplant; 2016; 25(3):517-30. PubMed ID: 26132529
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury.
Lee JW; Kim SC; Ko YS; Lee HY; Cho E; Kim MG; Jo SK; Cho WY; Kim HK
Biochem Biophys Res Commun; 2014 Feb; 444(2):121-7. PubMed ID: 24434153
[TBL] [Abstract][Full Text] [Related]
20. Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice.
Khang AR; Kim DH; Kim MJ; Oh CJ; Jeon JH; Choi SH; Lee IK
Diabetes Metab J; 2024 May; 48(3):405-417. PubMed ID: 38311057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
